Evaluation of flare rate and reduction strategies for bDMARDs in juvenile idiopathic arthritis: real world data from a single-centre cohort

Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry

(2021) Franz Thiele et al.   RHEUMATOLOGY INTERNATIONAL

Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible?

(2020) Inge R. Klein-Wieringa et al.   CURRENT OPINION IN RHEUMATOLOGY

Treatment Withdrawal Following Remission in Juvenile Idiopathic Arthritis: A Systematic Review of the Literature

(2019) Olha Halyabar et al.   PEDIATRIC DRUGS

Treating juvenile idiopathic arthritis to target: recommendations of an international task force

(2018) Angelo Ravelli et al.   ANNALS OF THE RHEUMATIC DISEASES

Biologics for the treatment of Juvenile Idiopathic Arthritis

(2018) Dimitri Poddighe et al.   CURRENT MEDICINAL CHEMISTRY

Predictors of Flare Following Etanercept Withdrawal in Patients with Rheumatoid Factor–negative Juvenile Idiopathic Arthritis Who Reached Remission while Taking Medication

(2018) Angela Aquilani et al.   JOURNAL OF RHEUMATOLOGY

Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration

(2018) Gabriele Simonini et al.   ARTHRITIS CARE & RESEARCH

Risk, Timing and Predictors of Disease Flare after Discontinuation of Anti-Tumor Necrosis Factor (TNF) Therapy in Children with Polyarticular Forms of Juvenile Idiopathic Arthritis (JIA) in Clinical Inactive Disease

(2018) Daniel J. Lovell et al.   Arthritis & Rheumatology

Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial

(2018) Petra Hissink Muller et al.   ANNALS OF THE RHEUMATIC DISEASES

Impact of juvenile idiopathic arthritis on quality of life during transition period at the era of biotherapies

(2016) Julien Wipff et al.   JOINT BONE SPINE

The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort

(2015) Jaime Guzman et al.   ANNALS OF THE RHEUMATIC DISEASES

Impact of Medication Withdrawal Method on Flare-Free Survival in Patients with Juvenile Idiopathic Arthritis on Combination Therapy

(2015) Caroline Y. Chang et al.   ARTHRITIS CARE & RESEARCH

Clinical trial of etanercept tapering in juvenile idiopathic arthritis during remission

(2013) Yubo Cai et al.   RHEUMATOLOGY INTERNATIONAL

Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-α therapy: a clinical practice observational study of patients who discontinued treatment

(2013) Estíbaliz Iglesias et al.   RHEUMATOLOGY INTERNATIONAL

Clinical remission in juvenile idiopathic arthritis after termination of etanercept

(2012) Jacek Postępski et al.   RHEUMATOLOGY INTERNATIONAL

EULAR recommendations for vaccination in paediatric patients with rheumatic diseases

(2011) M. W. Heijstek et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical outcomes after withdrawal of anti-tumor necrosis factor α therapy in patients with juvenile idiopathic arthritis: A twelve-year experience

(2011) Kevin Baszis et al.   ARTHRITIS AND RHEUMATISM

Juvenile idiopathic arthritis

(2011) Berent Prakken et al.   LANCET

Discontinuation of Etanercept After Successful Treatment in Patients with Juvenile Idiopathic Arthritis

(2010) A. REMESAL et al.   JOURNAL OF RHEUMATOLOGY

When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis

(2009) F H M Prince et al.   ANNALS OF THE RHEUMATIC DISEASES